Max Healthcare Institute Ltd
Max Healthcare Institute Ltd (MAXHEALTH) last traded at ₹1,015, a market capitalisation of ₹98,788 crore, on a P/E of 66.0. Over the past 52 weeks the stock has ranged between ₹903 and ₹1,222. Max Healthcare Institute Ltd last reported results for the quarter ended Jun 2026, with sales of ₹2,366 crore and net profit of ₹323 crore. Figures are as of 25 Aug 2026 and are not real time.
Max Healthcare Institute Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Max Healthcare Institute Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2,366 cr, up 16.7% from ₹2,028 cr a year earlier. Net profit was ₹323 cr, up 4.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 |
| Expenses | 1,257 | 1,369 | 1,398 | 1,505 | 1,560 | 1,529 | 1,536 | 1,768 |
| Operating profit | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 |
| OPM % | 26% | 27% | 27% | 26% | 27% | 26% | 28% | 25% |
| Other income | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 |
| Interest | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 |
| Depreciation | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 |
| Profit before tax | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 |
| Tax % | 25% | 23% | 21% | 23% | -10% | 17% | 26% | 26% |
| Net profit | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 |
| EPS (₹) | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.09 | 3.52 | 3.32 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Max Healthcare Institute Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 2,508 | 3,937 | 4,563 | 5,406 | 7,028 | 8,373 | 8,712 |
| Operating profit | 407 | 951 | 1,241 | 1,493 | 1,849 | 2,243 | 2,318 |
| OPM % | 16% | 24% | 27% | 28% | 26% | 27% | 27% |
| Net profit | -138 | 605 | 1,104 | 1,058 | 1,076 | 1,442 | 1,457 |
| EPS (₹) | -1.42 | 6.24 | 11.37 | 10.88 | 11.07 | 14.82 | 14.98 |
TTM is the trailing twelve months to the most recent quarter.
Max Healthcare Institute Ltd growth and returns
- 10 Years
- %
- 5 Years
- 27%
- 3 Years
- 22%
- TTM
- 16%
- 10 Years
- %
- 5 Years
- 60%
- 3 Years
- 10%
- TTM
- 25%
- 10 Years
- %
- 5 Years
- 24%
- 3 Years
- 21%
- 1 Year
- -19%
- 10 Years
- 11%
- 5 Years
- 14%
- 3 Years
- 14%
- Last Year
- 15%
Max Healthcare Institute Ltd shareholding pattern
Promoters held 23.71% at Jun 2026, broadly unchanged since Jun 2025. FIIs 41.78% and DIIs 29.95%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.72% | 23.71% | 23.71% |
| FIIs | 57.29% | 56.93% | 54.74% | 54.76% | 51.80% | 50.55% | 45.39% | 41.78% |
| DIIs | 15.14% | 15.55% | 17.59% | 17.41% | 20.03% | 21.20% | 26.32% | 29.95% |
| Public | 3.84% | 3.77% | 3.94% | 4.09% | 4.43% | 4.52% | 4.58% | 4.55% |
| No. of shareholders | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 | 1,80,891 | 2,03,837 | 2,16,996 | 2,24,606 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Max Healthcare Institute Ltd corporate filings
- Transcript of Earnings Call held on August 14, 2026Company Updatehigh impact
Cruxal's analysis: Max Healthcare Institute Limited reported Q1 FY27 revenue growth of 16% YoY and operating…
Read the full analysis - Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has submitted a routine disclosure under Regulation 30 of…
Read the full analysis - Presentation for Investor ConferenceCompany Updatehigh impact
Cruxal's analysis: Max Healthcare Institute Limited reported a strong Q1 FY27, with net revenue of 2,835…
Read the full analysis - Newspaper Publication pertaining to Financial Results for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Limited has formally notified the stock exchanges regarding the…
Read the full analysis - Audio Recording of Earnings Call held on August 14, 2026Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Limited has formally notified the stock exchanges regarding the…
Read the full analysis - Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has submitted a routine disclosure under Regulation 30 of…
Read the full analysis - Presentation on earnings updates for the quarter ended June 30, 2026Company Updatehigh impact
Cruxal's analysis: Max Healthcare Institute Limited reported a strong Q1 FY27 performance with gross revenue…
Read the full analysis - Press Release - Max Healthcare Q1 revenue rises to Rs. 2,982 Cr, registering growth of 16% YoY; Network Operating EBITDA rises to Rs. 704 Cr, 15% YoY; Q1 PAT was Rs. 357 CrCompany Updatemedium impact
Cruxal's analysis: Max Healthcare reported Q1 revenue of Rs 2,982 crore, reflecting a 16% YoY growth, with…
Read the full analysis - Results - Financial Results for the quarter ended June 30, 2026Resulthigh impact
Cruxal's analysis: Max Healthcare Institute Limited reported consolidated revenue of 2,366 crore and net…
Read the full analysis - Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute has announced the allotment of equity shares pursuant to the…
Read the full analysis - Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has announced the grant of stock options to eligible…
Read the full analysis - Schedule of Investor ConferenceCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has issued an intimation regarding a scheduled investor…
Read the full analysis - Schedule of Earnings Call for Investors and AnalystsCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Limited has announced that it will host an earnings conference…
Read the full analysis - Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve unaudited standalone ....Board Meetinglow impact
Cruxal's analysis: Max Healthcare Institute Limited has formally notified the stock exchanges that its Board…
Read the full analysis - Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has filed a routine disclosure under Regulation 30 of the…
Read the full analysis - Minutes of 25th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has filed the official minutes of its 25th Annual General…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Max Healthcare Institute Ltd
Cruxal reads every Max Healthcare Institute Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.